Sara Elizabeth Townsley

Array ( [id] => 5490056 [patent_doc_number] => 20090291127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'TRANSDERMAL ANTI-DEMENTIA ACTIVE AGENT FORMULATIONS AND METHODS FOR USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/437403 [patent_app_country] => US [patent_app_date] => 2009-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7643 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291127.pdf [firstpage_image] =>[orig_patent_app_number] => 12437403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6562996 [patent_doc_number] => 20100272793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Controlled Release Hydraliazine Formulations' [patent_app_type] => utility [patent_app_number] => 12/427863 [patent_app_country] => US [patent_app_date] => 2009-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1104 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272793.pdf [firstpage_image] =>[orig_patent_app_number] => 12427863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10102620 [patent_doc_number] => 09138390 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-22 [patent_title] => 'Petrolatum based composition comprising greater than 10% silicone for improved feel while remaining stable' [patent_app_type] => utility [patent_app_number] => 12/423984 [patent_app_country] => US [patent_app_date] => 2009-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6924 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12423984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392182 [patent_doc_number] => 20090209495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'USE OF EDG RECEPTOR BINDING AGENTS IN CANCER' [patent_app_type] => utility [patent_app_number] => 12/420913 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14639 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209495.pdf [firstpage_image] =>[orig_patent_app_number] => 12420913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6340888 [patent_doc_number] => 20100247673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'Thyroid protection in sickle cell anemia treatment' [patent_app_type] => utility [patent_app_number] => 12/382836 [patent_app_country] => US [patent_app_date] => 2009-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3989 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247673.pdf [firstpage_image] =>[orig_patent_app_number] => 12382836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5474331 [patent_doc_number] => 20090247497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'FORMULATION AND USE OF ERGOSTA-7,22-DIEN-3BETA-OL' [patent_app_type] => utility [patent_app_number] => 12/406112 [patent_app_country] => US [patent_app_date] => 2009-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4372 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247497.pdf [firstpage_image] =>[orig_patent_app_number] => 12406112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539698 [patent_doc_number] => 20090221503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'USE OF RAPAMYCIN AND RAPAMYCIN DERIVATIVES FOR THE TREATMENT OF BONE LOSS' [patent_app_type] => utility [patent_app_number] => 12/398225 [patent_app_country] => US [patent_app_date] => 2009-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2604 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221503.pdf [firstpage_image] =>[orig_patent_app_number] => 12398225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539714 [patent_doc_number] => 20090221519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'COMBINATIONS OF RECEPTOR TYROSINE KINASE INHIBITOR WITH AN A1-ACIDIC GLYCOPROTEIN BINDING COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/397374 [patent_app_country] => US [patent_app_date] => 2009-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17015 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221519.pdf [firstpage_image] =>[orig_patent_app_number] => 12397374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007123 [patent_doc_number] => 20110059154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'CCR5 ANTAGONISTS AS PROPHYLACTICS FOR PREVENTING HIV INFECTION AND METHODS OF INHIBITING TRANSMISSION OF SAME' [patent_app_type] => utility [patent_app_number] => 12/919833 [patent_app_country] => US [patent_app_date] => 2009-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18178 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059154.pdf [firstpage_image] =>[orig_patent_app_number] => 12919833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514130 [patent_doc_number] => 20090214436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'DICHROMIC FLUORESCENT COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/370758 [patent_app_country] => US [patent_app_date] => 2009-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12330 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214436.pdf [firstpage_image] =>[orig_patent_app_number] => 12370758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6520785 [patent_doc_number] => 20100203150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Novel amphiphilic copolymers and fabrication method thereof' [patent_app_type] => utility [patent_app_number] => 12/320843 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 4670 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203150.pdf [firstpage_image] =>[orig_patent_app_number] => 12320843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6195597 [patent_doc_number] => 20110027352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'COMPOUNDS FOR USE IN THE TREATMENT OF NEUROPATHIC PAIN' [patent_app_type] => utility [patent_app_number] => 12/863380 [patent_app_country] => US [patent_app_date] => 2009-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12845 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027352.pdf [firstpage_image] =>[orig_patent_app_number] => 12863380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539843 [patent_doc_number] => 20090221648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'COMPOSITIONS FOR TREATMENT OF COGNITIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/338865 [patent_app_country] => US [patent_app_date] => 2008-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18739 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221648.pdf [firstpage_image] =>[orig_patent_app_number] => 12338865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580469 [patent_doc_number] => 20090175815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Antiperspirant or deodorant products' [patent_app_type] => utility [patent_app_number] => 12/316963 [patent_app_country] => US [patent_app_date] => 2008-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11747 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175815.pdf [firstpage_image] =>[orig_patent_app_number] => 12316963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431462 [patent_doc_number] => 20100152142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'CRYSTALLINE FORM II OF TIGECYCLINE AND PROCESSES FOR PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/325686 [patent_app_country] => US [patent_app_date] => 2008-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3897 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152142.pdf [firstpage_image] =>[orig_patent_app_number] => 12325686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7757224 [patent_doc_number] => 20120029083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'POLYMORPHIC FORMS OF ALISKIREN HEMIFUMARATE AND PROCESS FOR PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/742856 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9803 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029083.pdf [firstpage_image] =>[orig_patent_app_number] => 12742856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4521249 [patent_doc_number] => 07951393 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Keloid therapy' [patent_app_type] => utility [patent_app_number] => 12/268754 [patent_app_country] => US [patent_app_date] => 2008-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 4033 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951393.pdf [firstpage_image] =>[orig_patent_app_number] => 12268754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10882715 [patent_doc_number] => 08907095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-09 [patent_title] => 'Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119' [patent_app_type] => utility [patent_app_number] => 12/739531 [patent_app_country] => US [patent_app_date] => 2008-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61858 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12739531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363742 [patent_doc_number] => 08252807 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Methods of inhibiting the interaction between S100 and the receptor for advanced glycation end-products' [patent_app_type] => utility [patent_app_number] => 12/247635 [patent_app_country] => US [patent_app_date] => 2008-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 43 [patent_no_of_words] => 12835 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12247635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10533393 [patent_doc_number] => 09259006 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-16 [patent_title] => 'Antimicrobial compositions and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/243460 [patent_app_country] => US [patent_app_date] => 2008-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 23657 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12243460 [rel_patent_id] =>[rel_patent_doc_number] =>)